Agilent Technologies to Build New Facility in Colorado
News Aug 10, 2016
Agilent Technologies Inc. has acquired 20 acres in Weld County, Colorado, on which it plans to build a pharmaceutical manufacturing facility.
The expansion will enable the company to more than double its commercial manufacturing capacity for nucleic acid active pharmaceutical ingredients.
"The products manufactured at this site will be used by our customers to improve the lives of patients suffering from a variety of diseases," said Skip Thune, general manager of the company's Nucleic Acids Solutions Division. "At Agilent, we are committed to meeting the ever-increasing needs of our customers for oligonucleotides."
Researchers believe oligonucleotides (short DNA and RNA molecules) hold the potential to treat various forms of cancer, diabetes, muscular dystrophy and other disorders.
Thune noted that the expansion would result in about 150 to 200 new, permanent high-paying jobs.
"Colorado is thrilled to welcome Agilent Technologies to the state," said Gov. John Hickenlooper. "This expansion will enhance Colorado's skilled workforce and dedication to research and development firms. We look forward to supporting Agilent's innovative work in our state."
"The Agilent project is a huge win for the Town of Frederick, Weld County and all of Northern Colorado," said Mike Freeman, chairman of the Weld County Commissioners. "The project adds diversification to our thriving economic base, plus significant new jobs and tax base. It also showcases what an amazing growth region Northern Colorado is due to the diverse workforce and business-friendly environment."
"The impact of new high-paying jobs and millions of dollars in investment will trigger a huge positive ripple through the local economy, pumping new revenue into everything from restaurants to housing," added Tony Carey, mayor of Frederick. "Winning this project shows the tremendous assets of Frederick and Weld County, and we welcome Agilent to our community."
"Local support paved the way for the Agilent project, and it's a great example of local governments working together to proactively accomplish a significant economic development project," said Tom Haren, chairman of the Upstate Colorado Economic Development Board.
Upstate Colorado coordinated the project with the Town of Frederick, Weld County and the State of Colorado to accommodate the needs of Agilent.
Drug Transport Gene May Explain Why Ovarian Cancer Patients React Differently to ChemotherapyNews
A gene which produces a protein that transports drugs in and out of cells may explain why some women treated with chemo have serious side effects.READ MORE
DETECTR Sniffs Out DNA Signals Using CRISPR-Cas9's CousinNews
A new technology allows amplification and detection of genomic snippets present in a sample, using the enzyme Cas12.READ MORE